DPP4 and Peritoneal Fibrosis: In conclusion, our results of cell level and animal model studies, and clinical observational findings showed that DPP4 enzyme played a key contributor to the peritoneal fibrosis and functional impairment, whereas DPP4 inhibitors safeguarded PD from dysfunction and failure.